These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31485618)

  • 1. Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase‑dependent apoptosis.
    Kaufman-Szymczyk A; Majda K; Szuławska-Mroczek A; Fabianowska-Majewska K; Lubecka K
    Mol Med Rep; 2019 Oct; 20(4):3597-3608. PubMed ID: 31485618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of clofarabine in ALL inhibition through DNA methylation regulation.
    Kaufman-Szymczyk A; Lubecka K
    Acta Biochim Pol; 2020 Jan; 67(1):65-72. PubMed ID: 31999420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells.
    Lubecka K; Kaufman-Szymczyk A; Cebula-Obrzut B; Smolewski P; Szemraj J; Fabianowska-Majewska K
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
    Stefanska B; Salamé P; Bednarek A; Fabianowska-Majewska K
    Br J Nutr; 2012 Mar; 107(6):781-90. PubMed ID: 21801466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
    Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
    Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside.
    Stagno F; Guglielmo P; Consoli U; Inghilterra G; Giustolisi GM; Palumbo GA; Giustolisi R
    Acta Haematol; 2000; 104(2-3):57-64. PubMed ID: 11154976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?
    Vatanmakanian M; Tavallaie M; Ghadami S
    Cell Commun Signal; 2019 Apr; 17(1):38. PubMed ID: 31014357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
    Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
    Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATRA promotes alpha tocopherol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients.
    Kumar S; Khanduja KL; Verma N; Verma SC; Avti PK; Pathak CM
    Mol Cell Biochem; 2008 Jan; 307(1-2):109-19. PubMed ID: 17874176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phytochemical brazilin suppress DNMT1 expression by recruiting p53 to its promoter resulting in the epigenetic restoration of p21 in MCF7cells.
    Chatterjee B; Ghosh K; Swain A; Nalla KK; Ravula H; Pan A; Kanade SR
    Phytomedicine; 2022 Jan; 95():153885. PubMed ID: 34920321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia.
    Kamachi K; Ureshino H; Watanabe T; Yoshida N; Yamamoto Y; Kurahashi Y; Fukuda-Kurahashi Y; Hayashi Y; Hirai H; Yamashita S; Ushijima T; Okada S; Kimura S
    Cancer Lett; 2022 Feb; 526():273-283. PubMed ID: 34875342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins.
    You L; Liu H; Huang J; Xie W; Wei J; Ye X; Qian W
    Oncotarget; 2017 Jan; 8(5):7777-7790. PubMed ID: 27999193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depleting long noncoding RNA HOTAIR attenuates chronic myelocytic leukemia progression by binding to DNA methyltransferase 1 and inhibiting PTEN gene promoter methylation.
    Song H; Chen L; Liu W; Xu X; Zhou Y; Zhu J; Chen X; Li Z; Zhou H
    Cell Death Dis; 2021 May; 12(5):440. PubMed ID: 33941772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1.
    Xu Y; Su D; Zhu L; Zhang S; Ma S; Wu K; Yuan Q; Lin N
    J Ovarian Res; 2018 May; 11(1):39. PubMed ID: 29759079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells.
    Stefanska B; Rudnicka K; Bednarek A; Fabianowska-Majewska K
    Eur J Pharmacol; 2010 Jul; 638(1-3):47-53. PubMed ID: 20447390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells.
    Li Y; Liu X; Guo X; Liu X; Luo J
    Leuk Res; 2017 Jul; 58():9-13. PubMed ID: 28376405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
    Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation.
    Miftakhova R; Sandberg T; Hedblom A; Nevzorova T; Persson JL; Bredberg A
    Anticancer Res; 2012 Nov; 32(11):4715-22. PubMed ID: 23155234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.